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1. Introduction  
Diabetic neuropathy is the most common long-term complication of Type 1 and Type 2 
diabetes, affecting approximately 10% within a year of diagnosis to 50% of subjects with 
diabetes for more than 25 years. Prevalence rates depend on diagnostic technique and the 
population under study (Dahlin et al., 2011; Rubino et al., 2007). Diabetic neuropathy 
associated with Type 1 diabetes tend to be more frequent, and develop more rapidly than in 
Type 2 diabetes. Gender differences seem to exist with males being more affected by 
neuropathy than females (Booya et al., 2005; Aaberg et al., 2008). Diabetes mellitus imposes 
a considerable burden on the nervous system and is the most common cause of peripheral 
nerve damage associated with a vast spectrum of neuropathy syndromes. The primary risk 
factor for the development of diabetic neuropathy is related to duration and severity of 
hyperglycaemia. Other independent risk factors for diabetic neuropathy include 
hypertension, hypercholesterolemia, smoking, increased body mass index and the presence 
of other complications of diabetes such as retinopathy and nephropathy (Adler et al., 1997). 
Diabetic neuropathy affects somatic as well as autonomic neurons of the peripheral nervous 
system with resultant morbidity and mortality for the patients and economic cost for the 
society and health care system. Interactions of pathogenic metabolic and vascular factors are 
responsible for the development of diabetic neuropathy. These complex mechanisms, which 
are not fully understood, need further clarification in order to develop new treatment 
strategies. The aim of this chapter is to describe methods and result in the evaluation of 
small and large nerve fibre pathology on the upper extremity.     
2. Small nerve fibre morphology  
Epidermal nerve fibres are predominantly unmyelinated C-fibres, which originate from the 
dorsal root ganglion, and are responsible for conveying thermal and nociceptive painful 
sensation. Small nerve fibres are believed to degenerate early in the course of diabetic 
neuropathy, and may even be affected in patients with impaired glucose tolerance (Loseth et 
al., 2008; Nebuchennykh et al., 2008).  
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An accepted method to evaluate small nerve fibre pathology is quantification of 
intraepidermal nerve fibre density (IENFD) using immunostaining with the cytoplasmatic 
neuronal marker protein gene product 9.5.  In accordance with recommendations from the 
European Federation of Neurological Societies, the majority of studies report on results from 
the lower extremity (Lauria et al., 2005). It is generally believed that IENFD decreases with 
age, while the influence of gender seems controversial (Goransson et al., 2004). In healthy 
subjects, as well as in asymptomatic diabetic patients, a length dependent reduction of 
IENFD has been demonstrated (Umapathi et al., 2007). Using IENFD quantification at the 
ankle, the diagnosis of diabetic peripheral neuropathy was reported to have a sensitivity 
and specificity of about 75%.  Skin biopsy has been reported to be the most sensitive 
measure for pre-diabetic neuropathy compared to nerve conduction studies, quantitative 
sensory testing, and a neuropathy score system (Smith et al., 2006). 
A reduction in unmyelinated nerve fibre density has been established from skin biopsies on 
the lower leg as well as from sural nerve biopsy of patients with diabetes. Sorensen et al. 
(2006) demonstrated a significantly lower IENFD in a group of patients with diabetes 
having painful neuropathy in the lower extremity compared to a group of patients without 
pain. Likewise, other reports from studies on the lower leg have indicated that a reduction 
in IENFD among patients with diabetes may primarily be related to those suffering from 
painful small fibre neuropathy (Quattrini et al., 2007). On the other hand, complete 
denervation of the epidermis can be seen in patients with genetic insensitivity to pain, 
questioning whether loss of IENF is related to pain, or should be judged only as an indicator 
of neuropathy (Nolano et al., 2000). 
Studies of IENFD in the upper extremity are sparse and have shown divergent results.  
Based on skin biopsies from the distal forearm a considerably reduced IENFD was 
demonstrated in patients with neuropathy compared to a healthy control group (Chien et 
al., 2001). However, aetiologies behind the neuropathy patient group were mixed with only 
14% of the cases being due to diabetes.  Another study compared skin biopsies of the 
forearm and the lower extremity in patients with diabetes, patients without diabetes 
suffering from neuropathy of different origin, and in a healthy control group (Pittenger et 
al., 2004). They demonstrated a significant difference in IENFD in the distal leg, but not in 
the forearm comparing patients with healthy controls subjects.  
Normative range of IENFD in the wrist area has been investigated in two studies. Using 
immunofluorescence and light microscopy on 15μm thick sections from skin biopsies of 
various areas of the hand an IENFD of 10.3±8.3/mm (mean±SD) in glabrous skin of the 
proximal palm was reported. It was noted that inter-individual variability was high and that 
no specific pattern of distribution was found from fingertips to the palm (Kelly et al., 2005). 
A study on hairy skin from the distal forearm, using bright-field immunohistochemistry on 
50μm thick sections reported a higher IENFD of 17.3±6.2/mm (Pan et al., 2001). Whether the 
difference in these results are caused by the study population, quantification technique or 
morphology in the hairy and glabrous skin remains unanswered as no comparative study 
on IENFD at the same anatomical level was performed. 
In a recent study with matched patient groups, skin biopsies taken from hairy and glabrous 
skin at wrist level, demonstrated no difference in IENFD between patient with and without 
diabetes (Thomsen et al., 2009b). Furthermore, no differences were found between patients 
with Type 1 or Type 2 diabetes, or between subgroups of patients with diabetes with or 
without peripheral neuropathy.  In addition, for both patients with and without diabetes, 
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IENFD was significantly higher in females compared to males and in hairy compared to 
glabrous skin. This is interesting, with the reported higher frequency of diabetic neuropathy 
in males than in females, suggesting that subjects with lower nerve fibre density would be 
more prone to develop neuropathy (Aaberg et al., 2008). Glabrous skin has been reported to 
have a higher heat pain threshold than hairy skin. Neurophysiological studies on monkeys 
provided a possible explanation for this phenomenal. The Aδ fibres consisted of both high 
threshold heat nociceptors and low threshold heat nociceptors, with glabrous skin being 
sparsely, if at all, innervated with low threshold Aδ fibres (Treede at al., 1995). Performing 
contact heat evoked potential stimulation others have confirmed these findings, that the 
glabrous surface of the hand is paucity innervated by low threshold nociceptors. These 
results on different nociceptive thresholds and receptors in glabrous versus hairy skin 
together with reported difference in thermal pain thresholds between male and female 
could explain these differences in the IENFD (Meh & Denislic, 1994). Furthermore, in order 
to functionally balance important inputs to the exploring surface of the glabrous skin, it 
seems reasonable that density of intraepidermal nociceptive nerve fibres is lower compared 
to the hairy skin. 
  
 
Fig. 1. Intraepidermal nerve fibre (arrow) from the dorsum of the wrist. Immunostained 
with protein gene product 9.5. Bar = 25 μm. 
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Small nerve fibres can also be assessed from a sural nerve biopsy. However, the biopsy 
procedure may cause long-term discomfort for the patient (Dahlin et al., 1997) and 
evaluation requires access to electron microscopy. A study, where patients underwent skin 
as well as sural nerve biopsy, concluded that IENFD measurement in the skin was more 
sensitive than evaluation of sural nerve biopsy to identify small fibre neuropathy 
(Herrmann et al., 1999). 
As a non-invasive method for assessment of neuropathy, corneal confocal microscopy 
allows in vivo visualization of small nerve fibres in the cornea without taking a biopsy 
(Quattrini et al., 2007). The extent of corneal nerve damage and repair can be accurately 
defined. Reduction in corneal nerve density has been demonstrated to correlate with the 
severity of somatic neuropathy defined by intraepidermal nerve fibre loss. Abnormalities 
have been detected in minimal and mild neuropathy. Furthermore, nerve regeneration and 
its response to therapy may be quantified by detecting changes in corneal nerve branch 
density and tortuosity.  
3. Large nerve fibre morphology  
Sural nerve biopsy has been the method of choice to undertake neuropathological 
assessment for the diagnosis of peripheral neuropathies of unknown cause. Biochemical 
analysis can be performed, such as assessment of sorbitol, fructose and myo-inositol levels, 
which relates to clinical neuropathy (Sundkvist et al., 2000). Furthermore, it has been used to 
gain insight to the underlying pathology of nerve damage in diabetes. Due to the potential 
complication following sural nerve biopsy (wound infection, persistent pain, dysaesthesia of 
the affected skin, sensory loss and patient dissatisfaction with the procedure), demonstrated 
for both type 1 and type 2 diabetes, such procedures should be restricted to carefully 
selected cases and performed at surgical centres with a special interest in this field (Dahlin 
et al., 1997). Nerve biopsies require careful managing and evaluation by an experienced 
neuropathologist. For obvious reasons, most of our insight into nerve pathology relies on 
experimental studies.  
From evaluation of sural nerve biopsies, it is known that the principal pathological lesions 
in human diabetic neuropathy are axonal degeneration and regeneration with loss of large 
myelinated nerve fibres, and segmental demyelination (Veves et al., 1991; Malik et al., 
2005). Endoneurial microangiopathy has been demonstrated in such biopsies including 
basement membrane thickening, pericyte degeneration, endothelial cell hyperplasia, and 
luminal narrowing.  Myelinated nerve fibre density has proven a reliable indicator of 
neuropathy in diabetic patients, correlating with clinical findings as well as to nerve 
conduction studies (Malik et al., 2001). Furthermore, a low myelinated fibre density may 
predict future nerve fibre loss and progression of neuropathy with time (Thrainsdottir et 
al., 2009).   
With progression of disease, diabetic neuropathy may also affect the upper limb, in 
particular the mononeuropathies. Owing to the described morbidity of a nerve biopsy, as 
well as the length-dependent nature of diabetic neuropathy, only a few publications 
describe morphology of nerves in the upper limb. Due to limitations in acquiring a biopsy, 
which fulfils the criteria for nerve biopsy in the upper limb, results have so far have been 
provided from post-mortem subjects or amputated limbs (Reske-Nielsen & Lundbaek, 
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1968). Furthermore, the number of included cases are small, predominantly paraffin sections 
with limited detailed quantification.  
In a post-mortem study of subclinical entrapment of the median and ulnar nerves a 
thickening of the perineurium and epineurium were observed. Furthermore, teased fibre 
analysis revealed thinning and retraction of the myelin as well as intercalated segments, 
suggestive of previous demyelination (Neary et al., 1975).  The limited amount of human 
nerve tissue available for analysis, make us reliant on experimental models in order to 
understand the pathological features of nerve compression. It is clear that animal models 
with application of compression clamps or silicon tubes around a nerve, however 
valuable, are not an authentic reflection of chronic nerve compression in humans. 
However, acute and chronic compression models may serve as prototypes for analysis of 
intracellular signalling in Schwann cells and neurons during and after nerve compression 
(Dahlin et al., 2008). Acute nerve compression differs from chronic nerve compression 
involving mechanisms such as inflammation, and stretching and tethering of the nerve 
during joint movements. Schwann cells are believed to be one of the primary mediators of 
demyelination seen in nerve compression, possibly initiated by mechanical stimulus 
(Gupta & Steward, 2003).  
Recently, a low morbidity procedure was presented, to assess large fibre pathology of the 
upper extremity (Thomsen et al., 2009a). The posterior interosseous nerve (PIN) biopsy is 
performed on the distal part of the dorsal forearm. The PIN is located on the interosseous 
membrane in the bottom of the fourth extensor compartment (Fig.2).  A 3-4 cm long nerve 
biopsy can be harvested. Morphologic assessment of the PIN biopsies demonstrated a 
reduced myelinated nerve fibre density in patients with Type 2 diabetes compared to 
autopsy control subjects (Fig.2). It was argued that the PIN biopsy procedure fulfils the 
criteria for nerve biopsy described by Dyck (1968) as it has a constant location, is easy 
accessible, leaves no sensory or motor deficit and it is seldom subjected to trauma or 
entrapment. Furthermore, if a corroborative functional assessment is desirable, nerve 
conduction studies can be performed on the superficial sensory branch of the same nerve 
and at the same distal level as the nerve biopsy. The posterior interosseous nerve biopsy, 
performed under local anaesthesia and well tolerated by the patients, enables for the first 
time a larger scale human evaluation of nerve morphology in diabetes.  
The posterior interosseous nerve biopsy performed on patients with carpal tunnel 
syndrome, demonstrated a significant reduction in myelinated nerve fibre and endoneurial 
capillary densities in patients with diabetes compared to patients without diabetes 
(Thomsen et al., 2009c). Surprisingly, these parameters were reduced for both patients with 
and without diabetes having carpal tunnel syndrome, compared to healthy control subjects 
without carpal tunnel syndrome. The finding suggests that distinct nerve pathology may 
exist even in patients without diabetes with idiopathic carpal tunnel syndrome. A reduction 
in endoneurial capillary density, which ultimately will lead to reduced endoneurial 
oxygenation, provides the first mechanistic foundation for axonal nerve damage through a 
hypoxic endoneural environment. A reduced number of nerve fibres may therefore 
represent an inborn impaired reserve capacity for the peripheral nervous system. Although 
not quantified, microangiopathy with reduplication of the basement membrane and 
thickening of the endothelium was observed in some of the diabetic patients. Gender 
differences need further investigation as a resent study on large nerve fibre function, 
represented by vibrotactile sense and electrophysiology demonstrated impaired function in 
males compared to females (Dahlin et al., 2011).  
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Fig. 2. Technique of the biopsy procedure. (a) Landmark for the incision is one 
fingerbreadth proximal to the ulnar head. The PIN and the anterior interosseous artery 
are seen on the interosseous membrane. (b) Cross-section of the distal forearm. The PIN 
(arrow) and the anterior interosseous artery are found in the bottom of the fourth extensor 
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compartment lying on the interosseous membrane.Light microscopic image of a PIN 
fascicle from (c) an autopsy control subject and (d) a diabetic subject. Note the lower 
myelinated fibre density in the diabetic patient compared to the autopsy control. From 
another patient (e) a PIN fascicle and (f) a sural nerve fascicle. Observe the lower 
myelinated fibre density in the sural nerve fascicle compared to the PIN fascicle. 
Reproduced with the courtesy of Wiley-Blackwell.  
3. Conclusion  
When evaluating small nerve fibre pathology in the upper extremity it is important to 
consider that the intraepidermal nerve fibre density is higher in female than in males and 
higher in hair than in glabrous skin. Differences between patients with and without diabetes 
needs further attention.  
Studies on nerve morphology in the upper extremity can provide useful insight into the 
pathophysiology of diabetic neuropathies. Patients with diabetes demonstrate significant 
reduction in myelinated nerve fibre and endoneurial capillary densities in the upper 
extremity compared to patients without diabetes. These factors may predispose patients 
with diabetes to compression neuropathy, which is found with increased prevalence 
compared to patients without diabetes.   
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